BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23090289)

  • 21. Relationship between genetic polymorphisms in MCP-1, CCR-2, and non-small-cell lung cancer in the Han nationality of Northern China.
    Yang L; Wang J; Li FG; Han M; Chang XJ; Wang ZT
    Genet Mol Res; 2015 Apr; 14(2):3745-52. PubMed ID: 25966143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes.
    Inose Y; Kato Y; Kitagawa K; Uchiyama S; Shibata N
    Neuropathology; 2015 Jun; 35(3):209-23. PubMed ID: 25443158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte chemotactic protein (MCP)-1 (CCL2) and its receptor (CCR2) are elevated in chronic heart failure facilitating lung monocyte infiltration and differentiation which may contribute to lung fibrosis.
    Puukila S; Lawrence MD; De Pasquale CG; Bersten AD; Bihari S; McEvoy-May J; Nemec-Bakk A; Dixon DL
    Cytokine; 2023 Jan; 161():156060. PubMed ID: 36219898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells.
    Futagami S; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Nobue U; Shinji Y; Suzuki K; Kusunoki M; Tanaka S; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):137-46. PubMed ID: 18093816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
    Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.
    Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ
    Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
    Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
    Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
    Sica A; Saccani A; Bottazzi B; Bernasconi S; Allavena P; Gaetano B; Fei F; LaRosa G; Scotton C; Balkwill F; Mantovani A
    J Immunol; 2000 Jan; 164(2):733-8. PubMed ID: 10623817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).
    Tan JH; Canals M; Ludeman JP; Wedderburn J; Boston C; Butler SJ; Carrick AM; Parody TR; Taleski D; Christopoulos A; Payne RJ; Stone MJ
    J Biol Chem; 2012 Apr; 287(18):14692-702. PubMed ID: 22396538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
    Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
    Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chemokine receptor CCR2 mediates the binding and internalization of monocyte chemoattractant protein-1 along brain microvessels.
    Dzenko KA; Andjelkovic AV; Kuziel WA; Pachter JS
    J Neurosci; 2001 Dec; 21(23):9214-23. PubMed ID: 11717355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain.
    Galasso JM; Miller MJ; Cowell RM; Harrison JK; Warren JS; Silverstein FS
    Exp Neurol; 2000 Oct; 165(2):295-305. PubMed ID: 10993690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).
    Tan JHY; Ludeman JP; Wedderburn J; Canals M; Hall P; Butler SJ; Taleski D; Christopoulos A; Hickey MJ; Payne RJ; Stone MJ
    J Biol Chem; 2013 Apr; 288(14):10024-10034. PubMed ID: 23408426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis.
    Xu YK; Ke Y; Wang B; Lin JH
    Biol Res; 2015 Nov; 48():64. PubMed ID: 26578310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
    Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
    J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells.
    Janssen U; Sowa E; Marchand P; Floege J; Phillips AO; Radeke HH
    Nephron; 2002 Dec; 92(4):797-806. PubMed ID: 12399623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.
    Giunti S; Pinach S; Arnaldi L; Viberti G; Perin PC; Camussi G; Gruden G
    Kidney Int; 2006 Mar; 69(5):856-63. PubMed ID: 16518346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS.
    Kawaguchi-Niida M; Yamamoto T; Kato Y; Inose Y; Shibata N
    Acta Neuropathol Commun; 2013 Jun; 1():21. PubMed ID: 24252211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.